Astellas US Holding, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 2005, Astellas has rapidly evolved, focusing on innovative solutions in areas such as oncology, urology, and immunology. The company is renowned for its commitment to research and development, which has led to the creation of unique therapies that address unmet medical needs. With a strong market position, Astellas has achieved significant milestones, including the successful launch of several key products that enhance patient outcomes. The company’s dedication to advancing healthcare through cutting-edge science and patient-centric approaches sets it apart in a competitive landscape. Astellas continues to strive for excellence, making a meaningful impact on global health.
How does Astellas US Holding, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Astellas US Holding, Inc.'s score of 66 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Astellas US Holding, Inc. currently does not report specific carbon emissions data, as no emissions figures are available. However, the company is part of a corporate family that includes Astellas Pharma Inc., which may influence its climate commitments and initiatives. Astellas Pharma Inc. has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives are cascaded to Astellas US Holding, Inc. as a current subsidiary, indicating a commitment to reducing carbon emissions in alignment with industry standards. While specific reduction targets or achievements for Astellas US Holding, Inc. are not detailed, the overarching goals from Astellas Pharma Inc. suggest a proactive approach to addressing climate change. The company is expected to align its strategies with these broader commitments, focusing on sustainability and emissions reduction in its operations.
Access structured emissions data, company-specific emission factors, and source documents
| 2005 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 108,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 |
Astellas US Holding, Inc.'s Scope 3 emissions, which increased by 14% last year and decreased by approximately 7% since 2015, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 85% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Astellas US Holding, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.